Revising the language of addiction

August 29, 2017
Revising the language of addiction
HMS Professor John Kelly helped to create the "Addiction-ary," a glossary of addiction-related terms to help medical professionals and the general public modify their language about addiction. Graphic by Rebecca Coleman/Harvard Staff

When confronting the power of addiction, the power of language is important to keep in mind, specialists say.

The Diagnostic and Statistical Manual of Mental Disorders, the American Psychiatric Association's diagnostic handbook, describes someone struggling with addiction as having "opioid use disorder." But many of us are more familiar with "drug abuser," as well as the term's negative connotations.

"It's so hard for people to give up the 'abuse' word," said Sarah Wakeman, medical director of the Substance Use Disorders Initiative and the Addiction Consult Team at Harvard-affiliated Massachusetts General Hospital (MGH), during an interview at her office.

Wakeman has written frequently on the topic, urging people to adopt medically accurate, "person-first" language.

The terms "abuse" and "abuser," she wrote in an article published last year by the American Society of Addiction Medicine, "imply a willful misconduct and have been shown to increase stigma and reduce the quality of care." Equally harmful, she added, is the language often applied to the most effective form of treatment.

"The stigma surrounding the use of pharmacotherapy, in particular opioid agonist therapy, is arguably more potent and harmful than the general stigma about addiction," Wakeman wrote. Drugs such as buprenorphine, which can curb cravings and withdrawal symptoms, are too often called a "replacement addiction." To counter that misconception, the use of buprenorphine, which is marketed under the brand name Suboxone, should simply be called "treatment" rather than "medication-assisted treatment," Wakeman said.

For Wakeman and other specialists, the distinction between "dependency" and "addiction," two terms that are often interchanged, needs to be made clear. Many people who use an opioid to treat chronic pain become dependent on the drug, meaning if they stop taking it they will go through withdrawal, said Wakeman. By contrast, addiction is a medical disorder in which "you are compulsively using more and more of a drug that can cause bad things to happen in your life."

Descriptions such as "clean" and "dirty" also have to go, Wakeman said.

"A doctor would never tell a patient suffering from diabetes that their blood was dirty with glucose," said Wakeman, demonstrating her simple rule for language choices.

"We should ask, 'Is this a term that we would use for another medical condition?' If the answer is 'no,' we shouldn't use it."

For many, the first step toward recovery means admitting a problem. In abstinence programs such as Alcoholics Anonymous participants often say their name followed by the statement "and I'm an alcoholic." While Wakeman urges people to say whatever makes them feel comfortable, from health care providers she expects "medically accurate terms."

"The power of language is so strong, and the stigma is so deeply felt," said Wakeman, who bristles at the terms "junkie" and "addict."

That power was clear in findings by Harvard Medical School's John Kelly, who in 2010 conducted a pair of studies to test his theory that people exposed to certain terms associated with addiction display unconscious biases.

Kelly, the Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine, crafted two descriptions of someone struggling with addiction. In one paragraph he referred to the person as a "substance abuser," which he believed might suggest the notion of willful misconduct and lead to more punitive approaches. In the other paragraph he wrote "substance use disorder," a term he thought might convey the idea of a medical malfunction and lead to less punitive, more treatment-oriented attitudes.

Kelly then randomly assigned the descriptions to 600 doctoral-level clinicians and asked them to answer a series of questions including whether the person should be punished or treated, whether he should be blamed for his condition, and whether he was a threat. Later Kelly repeated the test with the general population.

In both groups the research found that "individuals who were exposed to the 'substance abuser' term had much more punitive attitudes toward the subject than if he was described as having a substance use disorder," Kelly said.

After the Medical School published the findings in its Mental Health Letter, word spread. Kelly traveled to Washington, D.C., to meet with Michael Botticelli, then-director of the White House Office of National Drug Control Policy, and he presented the research at the first national drug policy reform summit in 2013. Soon the White House adopted his recommended terminology.

In 2015, Kelly spoke before the International Society of Addiction Journal Editors at a conference in Budapest. In response, the group formulated a consensus statement that recommends against using stigmatizing terminology, most notably "abuse" and "abuser," in published addiction science.

Another move influenced by his research, Kelly said, was the decision by the Associated Press to include a new entry on addiction and to revise drug-related entries in the latest edition of its stylebook.

The work continues. As the founder and director of MGH's Recovery Research Institute, Kelly helped created a web tool called the Addiction-ary, a glossary of addiction-related terms including several words that come with a bold "stigma alert" warning. The national nonprofit Facing Addiction has adopted the tool, he said.

"If we want destigmatized, we need a language that's unified and really accurately portrays the true nature of what we've learned about these conditions over the last 25 years," said Kelly.

"This goes beyond political correctness," he added. "It's not just a matter of being nice. What we now know is that actual exposure to these specific terms induces this implicit cognitive bias. If you really want to solve the problem, you want to remove any barriers and obstacles."

Explore further: ACOG: Opioid agonist Rx first choice in affected pregnancies

Related Stories

ACOG: Opioid agonist Rx first choice in affected pregnancies

July 28, 2017
(HealthDay)—While opioid agonist pharmacotherapy continues to be the recommended therapy for pregnant women with an opioid use disorder, medically supervised withdrawal can be considered under the care of a physician experienced ...

Starting opioid addiction treatment in the ED is cost-effective

August 16, 2017
The most cost-effective treatment for people with untreated opioid addiction who visit the emergency department (ED) is buprenorphine, a medication to reduce drug cravings and withdrawal, say Yale researchers. Their study ...

Addiction specialist explains fentanyl threat

June 28, 2017
As the opioid crisis rages across the United States, people suffering from addiction as well as the first responders, doctors, and counselors trying to help them are facing another deadly challenge: fentanyl, a synthetic ...

Opioids commission recommends that Trump declare a national emergency

August 1, 2017
The White House commission on opioid addiction has recommended that President Donald Trump declare a national emergency over the epidemic that each day kills dozens of Americans.

Who should treat patients with opioid use disorder?

July 11, 2017
In a Point/Counterpoint, two doctors debate whether or not family physicians should provide medication-assisted treatment to their patients with opioid use disorder.

Recommended for you

Glucocorticoids offer long-term benefits for patients with Duchenne muscular dystrophy

November 22, 2017
Glucocorticoids, a class of steroid hormone medications often prescribed to patients with Duchenne muscular dystrophy (DMD), offer long-term benefits for this disease, including longer preservation of muscle strength and ...

Baby-boomers and millennials more afflicted by the opioid epidemic

November 21, 2017
Baby-boomers, those born between 1947 and 1964, experienced an excess risk of prescription opioid overdose death and heroin overdose death, according to latest research at Columbia University's Mailman School of Public Health. ...

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Aug 29, 2017
What a nightmare. 250mg of healthy adult male facial skin surface lipid, or "face grease" taken by mouth 1 time cures opioid addiction without withdrawal symptoms.
You haven't heard? Sub-pheromone vapors from that much of the face grease pheromone stimulate aversive symptoms in researchers. That's why. People poking their noses in where they don't belong.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.